Literature DB >> 1281959

Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio.

M Maes1, W Stevens, L DeClerck, C Bridts, D Peeters, C Schotte, P Cosyns.   

Abstract

This study investigated the leukocyte T helper and T suppressor-cytotoxic cell (sub)set profile of minor, simple major and melancholic depressives versus normal controls. Using both monoclonal antibody staining and flow cytometry, we determined the absolute numbers and percentages of the following T cell immune subsets: T helper (CD4+), T virgin (CD4+CD45+), T memory (CD4+CD45-), T suppressor/cytotoxic (CD8+), CD8+ T suppressor (CD8+CD57-) and CD8+ T cytotoxic (CD8+CD57+) cells. After computing the CD4+/CD8+ ratio, we detected a significantly increased ratio in depressed patients as compared with healthy controls. Depression per se is characterized by a higher percentage of CD4+ and a lower percentage of CD8+CD57- cells. Melancholic depressed subjects exhibit a significantly increased number of CD4+ and CD4+CD45- cells. The combined use of various percentages of CD4+ and CD8+ (sub)sets yields a high degree of marker positivity for melancholia: through cumulative evaluation of those percentages, the marker positivity increases to 68% (sensitivity) and the specificity is 95%. These results together with our previous reports may refer to a depression-related state of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281959     DOI: 10.1111/j.1600-0447.1992.tb03292.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  15 in total

Review 1.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

2.  Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment.

Authors:  Andrine Lemieux; Christopher L Coe; Molly Carnes
Journal:  Brain Behav Immun       Date:  2008-04-18       Impact factor: 7.217

Review 3.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

Review 4.  The role of the kynurenine metabolism in major depression.

Authors:  Aye-Mu Myint; Markus J Schwarz; Norbert Müller
Journal:  J Neural Transm (Vienna)       Date:  2011-12-03       Impact factor: 3.575

Review 5.  An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes.

Authors:  Catherine Toben; Bernhard T Baune
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-02       Impact factor: 4.147

Review 6.  Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells.

Authors:  Eléonore Beurel; Eva M Medina-Rodriguez; Richard S Jope
Journal:  Pharmacol Rev       Date:  2022-04       Impact factor: 25.468

Review 7.  Contributions of the adaptive immune system to mood regulation: Mechanisms and pathways of neuroimmune interactions.

Authors:  Miles Herkenham; Stacey L Kigar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-09-06       Impact factor: 5.067

8.  Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study.

Authors:  Ruihua Hou; Matthew Garner; Clive Holmes; Clive Osmond; Jessica Teeling; Laurie Lau; David S Baldwin
Journal:  Brain Behav Immun       Date:  2017-02-01       Impact factor: 7.217

9.  Depressive symptoms post hip fracture in older adults are associated with phenotypic and functional alterations in T cells.

Authors:  Niharika Arora Duggal; Jane Upton; Anna C Phillips; Peter Hampson; Janet M Lord
Journal:  Immun Ageing       Date:  2014-12-16       Impact factor: 6.400

10.  Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.

Authors:  Levent Sutcigil; Cagatay Oktenli; Ugur Musabak; Ali Bozkurt; Adnan Cansever; Ozcan Uzun; S Yavuz Sanisoglu; Zeki Yesilova; Nahit Ozmenler; Aytekin Ozsahin; Ali Sengul
Journal:  Clin Dev Immunol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.